Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases
about
Integrative meta-analysis identifies microRNA-regulated networks in infantile hemangiomaNeoadjuvant chemotherapy (NCT) plus targeted agents versus NCT alone in colorectal liver metastases patients: A systematic review and meta-analysisPathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backboneImpact of homogeneous pathologic response to preoperative chemotherapy in patients with multiple colorectal liver metastases.Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials.
P2860
Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases
description
article
@en
im Mai 2015 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2015
@uk
name
Pathological response after ne ...... rectal cancer liver metastases
@en
Pathological response after ne ...... rectal cancer liver metastases
@nl
type
label
Pathological response after ne ...... rectal cancer liver metastases
@en
Pathological response after ne ...... rectal cancer liver metastases
@nl
prefLabel
Pathological response after ne ...... rectal cancer liver metastases
@en
Pathological response after ne ...... rectal cancer liver metastases
@nl
P2093
P2860
P50
P921
P1433
P1476
Pathological response after ne ...... rectal cancer liver metastases
@en
P2093
Cecilia Muscarà
Christian Cotsoglou
Flavia Melotti
Pamela Biondani
P2860
P2888
P356
10.1007/S12032-015-0638-3
P50
P577
2015-05-24T00:00:00Z